Literature DB >> 23934051

[Comorbidities in psoriatic arthritis].

W-H Boehncke1, S Boehncke.   

Abstract

Psoriatic arthritis occurs almost exclusively together with psoriasis (of the skin). Thus, psoriasis-associated diseases or comorbidities are also seen in psoriatic arthritis patients. Among the clinically most relevant comorbidities are cardiovascular diseases and their risk factors, namely smoking, obesity and the metabolic syndrome. Moreover, psychological conditions and osteoporosis should also be considered. The link between psoriasis, psoriatic arthritis and its comorbidities has been established based on epidemiological studies; however, at least for the cardiovascular comorbidities, the association can be explained based on novel insights into the pathogenesis of atherosclerosis. For the practising physician it is important to take into account the aspect of comorbidity to come to an optimal treatment decision in each individual case. Clinical decision-making is complicated further by the fact that comorbidity necessitates comedication which again influence the choice of treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23934051     DOI: 10.1007/s00393-013-1189-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  23 in total

1.  Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity.

Authors:  Enas A S Attia; Ayman Khafagy; Sameh Abdel-Raheem; Sahar Fathi; Abeer A Saad
Journal:  Int J Dermatol       Date:  2011-01       Impact factor: 2.736

2.  The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke; Anne-Marie Tobin; Brian Kirby
Journal:  Exp Dermatol       Date:  2011-04       Impact factor: 3.960

3.  Bone mineral density in patients with psoriatic arthritis.

Authors:  B Frediani; A Allegri; P Falsetti; L Storri; S Bisogno; F Baldi; P Filipponi; R Marcolongo
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

4.  Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis.

Authors:  B J Harrison; C E Hutchinson; J Adams; I N Bruce; A L Herrick
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  Bone mineral density and bone turnover in patients with psoriatic arthritis.

Authors:  Pinar Borman; Seçil Babaoğlu; Guneş Gur; Sezin Bingol; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

6.  Psoriasis is associated with lipid abnormalities at the onset of skin disease.

Authors:  Lotus Mallbris; Fredrik Granath; Anders Hamsten; Mona Ståhle
Journal:  J Am Acad Dermatol       Date:  2006-01-19       Impact factor: 11.527

7.  Psoriasis patients show signs of insulin resistance.

Authors:  S Boehncke; D Thaci; H Beschmann; R J Ludwig; H Ackermann; K Badenhoop; W-H Boehncke
Journal:  Br J Dermatol       Date:  2007-10-04       Impact factor: 9.302

8.  Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.

Authors:  P Gisondi; G Tessari; A Conti; S Piaserico; S Schianchi; A Peserico; A Giannetti; G Girolomoni
Journal:  Br J Dermatol       Date:  2007-06-06       Impact factor: 9.302

9.  Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis.

Authors:  S Gerdes; V A Zahl; H Knopf; M Weichenthal; U Mrowietz
Journal:  Br J Dermatol       Date:  2008-11       Impact factor: 9.302

10.  Prevalence of malignancy in psoriatic arthritis.

Authors:  Sherry Rohekar; Brian D M Tom; Agnes Hassa; Cathy T Schentag; Vernon T Farewell; Dafna D Gladman
Journal:  Arthritis Rheum       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.